UnitedHealthcare · Er OON · US health-plan appeal rights

Er OON denied as not FDA-approved for this use by UnitedHealthcare?

Q: How long do I have to appeal a UnitedHealthcare Er OON denial?

Internal appeal window: Typically 180 days from the denial date. External review window: Typically 60–120 days after the final internal denial. The clock starts from the date on the denial letter.

Off-label use is widespread in medicine. If the literature and a recognised specialty-society guideline support the use, plans frequently approve on appeal — especially for cancer, cardiology, and rare disease.

By Michael John Ryan, Founder & Privacy Officer, DenialHelp, LLC

Last reviewed 2026-05-10

Policy data current as of 2026-04-26

US health-plan appeal rights

Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules

Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.

Internal appeal window

Typically 180 days from the denial date

External review window

Typically 60–120 days after the final internal denial

What UnitedHealthcare typically requires

UnitedHealthcare's specific coverage criteria for er oon are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

Source policy: UHC Member Handbook + No Surprises Act Compliance

The UnitedHealthcare angle on Er OON

## Why UnitedHealthcare Denies Extended-Release Opioids as Not FDA-Approved

A "not FDA-approved" denial for an extended-release opioid typically arises in one of two scenarios: (1) the specific formulation prescribed was recently approved or is a novel delivery system that UHC's claims system has not yet recognized, or (2) the drug is being prescribed for an off-label indication — a condition or patient population not listed in the FDA-approved prescribing label. UHC's coverage policies generally restrict coverage to FDA-approved indications unless off-label use meets specific evidence standards.

## Why This Denial Is Appealable

If the use is on-label, the denial may be a claims-system error or a lag in UHC updating its drug database — correctable by submitting the FDA prescribing label and the drug's National Drug Code (NDC) with the appeal. If the use is off-label, most ACA-compliant and ERISA plans are required to cover off-label use supported by recognized compendia (e.g., DrugDEX, AHFS, or others accepted by the plan) or peer-reviewed medical literature; your appeal should document that evidentiary support.

## Federal Appeal Framework

Internal appeal: File within the deadline on your denial notice. UHC must respond within 60 days (post-service) or 30 days (pre-service).
Expedited review: Available within 72 hours when urgent health need is documented.
External review (ACA §2719 / ERISA §503): After exhausting internal appeal, file for independent external review within approximately four months. Binding on the insurer.

## Appeal Process and Timeline

1. Confirm with the prescriber whether the use is on-label or off-label relative to the current FDA prescribing label. 2. If on-label: attach the FDA label clearly showing the indication and request the plan correct its determination. 3. If off-label: obtain the relevant compendia citation(s) and/or peer-reviewed literature that UHC's policy accepts as evidence for off-label coverage. 4. Have the prescriber write a letter linking the patient's diagnosis to the supported indication and explaining the clinical rationale. 5. Submit the internal appeal; escalate to external review if denied.

## Documentation to Gather

FDA prescribing label: Current version showing approved indications.
Drug's NDC: To verify the specific product is properly identified in UHC's system.
Compendia or literature support: If off-label, identify which compendia or peer-reviewed sources UHC's policy accepts.
Prescriber letter of medical necessity: Connecting diagnosis to indication and citing supporting evidence.
Chart notes establishing diagnosis: Confirming the patient's condition matches the approved or supported indication.

## Criteria-Mapping Structure

Obtain UHC's relevant clinical coverage policy. List each criterion — particularly the FDA-approval or compendia-support requirement. For each, document the specific evidence that satisfies it: label text, compendia reference, or literature citation. Pair each with the prescriber's attestation and chart confirmation. Present this mapping in your appeal letter as a numbered point-by-point response.

Next steps

Find the date on the denial letter — your appeal window starts there.
Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
Request the insurer's claim file in writing — they must provide it.
Submit your appeal in writing with new clinical evidence and a physician statement.

Get the letter drafted

DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.

Start my appeal — $30 with code SEO25 →

Related appeal guides

Other UnitedHealthcare appeals

Other denial reasons for UnitedHealthcare Er OON

denied as not medically necessary denied for failing step therapy denied as non-formulary denied for missing prior authorization denied as experimental or investigational

This guide describes general US federal appeal rights based on Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules. Your specific plan documents (Summary of Benefits and Coverage, Evidence of Coverage) override anything here. DenialHelp is not your lawyer and not your physician — we draft appeal letters that your physician signs. Outcomes depend on your insurer's decision and factors outside our control. Reviewed by Michael John Ryan on 2026-05-10. Editorial standards: denialhelp.com/authors.